US 8252578
Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof
granted A61KA61K38/40A61K48/00
Quick answer
US patent 8252578 (Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof) held by Xenon Pharmaceuticals Inc. expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Xenon Pharmaceuticals Inc.
- Grant date
- Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K38/40, A61K48/00, A61P, A61P3/00